
Rheon Medical
Adjustable glaucoma drainage device to provide personalized control of post-operative intra-ocular pressure.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
CHF5.6m | Series C | ||
Total Funding | 000k |
EUR | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 1 % | (8 %) | 4 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Rheon Medical is a healthcare technology startup that specializes in the development and distribution of innovative ophthalmic devices. The company's flagship product, the eyeWatch, is a state-of-the-art device designed to help manage glaucoma, a condition that can lead to vision loss if not properly treated. The eyeWatch is a glaucoma shunt, a device that helps to reduce intraocular pressure (IOP), which is the pressure inside the eye. High IOP is a major risk factor for glaucoma.
The eyeWatch is unique in that it allows for titration, or the ability to adjust the flow of fluid from the eye to control IOP. This feature is particularly beneficial for patients who have had unsuccessful surgeries in the past or those who require specific postoperative care. The device's design is soft and flexible, making it an ideal solution for patients seeking a comfortable and effective treatment option.
Rheon Medical operates in the global ophthalmic medical device market, serving clients such as hospitals, clinics, and individual patients. The company's business model revolves around the production, marketing, and sale of the eyeWatch and potentially other innovative ophthalmic devices in the future. Revenue is generated through the sale of these devices to healthcare providers and patients.
Keywords: Rheon Medical, healthcare technology, ophthalmic devices, glaucoma, eyeWatch, intraocular pressure, titration, medical device market, innovative treatment, postoperative care.